BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37857912)

  • 21. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
    Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
    Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
    Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
    Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
    Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-Weighted Magnetic Resonance Imaging (DWI) Parameters in Benign and Malignant Ovarian Tumors with Solid and Cystic Components.
    Zhuang Y; Wang T; Zhang G
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):105-108. PubMed ID: 30700345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
    Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy.
    Diebold J; Seemüller F; Löhrs U
    Lab Invest; 2003 Feb; 83(2):251-8. PubMed ID: 12594239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic features of ovarian borderline tumors with invasive implant.
    Ohta T; Ohmichi M; Hayasaka T; Saitoh M; Kojimahara T; Kawagoe J; Nakahara K; Motoyama T; Kurachi H
    Arch Gynecol Obstet; 2005 Oct; 272(4):278-82. PubMed ID: 16012777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
    Zhang W; Wang L; Xin Z
    Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
    Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
    J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors.
    Hasbay E; Görgülü G; Sanci M; Özamrak BG
    Rev Assoc Med Bras (1992); 2023; 69(7):e20230110. PubMed ID: 37466596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center.
    Moro F; Mascilini F; Pasciuto T; Leombroni M; Li Destri M; De Blasis I; Garofalo S; Scambia G; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1182-1194. PubMed ID: 31326950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
    Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
    BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
    Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
    Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Insight on Exophytic Serous Borderline Adnexal Tumors: Specific Sonographic Features.
    Haddad L; Kugelman N; Shapiro I; Bakry H; Weizman B; Korobochka R; Sagie S; Said-Idris S; Bejar J; Leibovitz Z
    J Ultrasound Med; 2022 Jun; 41(6):1549-1557. PubMed ID: 34562042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.